Health Care Partner Stephanie Trunk will participate in the External Counsel Fireside Chat at Informa Connect’s Pricing & Contracting USA 2025 conference in Philadelphia, Pennsylvania, on May 21.
Health Care Partners Lowell Brown, Debra Albin-Riley, Annie Lee, and Jeff Weston will present at the California Association Medical Staff Services’ (CAMSS) 54th Annual Education Forum in Universal City, California, on May 14-16, 2025.
Within the last month, the US District Court for the Northern District of California rejected efforts by United Behavioral Health (UBH) to dismiss and decertify two class actions seeking relief related to UBH’s processing of mental health claims.
There are currently six states with active Prescription Drug Affordability Boards (PDABs) — Colorado, Maryland, Washington, Oregon, New Hampshire, and Minnesota.
Partner Douglas Grimm was quoted on the US Supreme Court’s ruling Loper Bright Enterprises v. Raimondo, marking one year since the landmark decision that ended judicial deference to agency rulemaking.
A litigation before a court in one jurisdiction may require taking third-party discovery from third parties located in different jurisdictions. Litigants seeking third-party discovery from parties in other states may quickly discover that the process can be more complex than expected.
ArentFox Schiff successfully represented Oura, known for its innovative health and fitness smart ring, in a US International Trade Commission (ITC) investigation for infringement of its patent by smart ring manufacturing competitors in China and India.
Ambulatory surgery centers (ASCs) have become a large and growing part of the health care industry. ASCs offer same-day surgical care, including diagnostic and preventive procedures, and their popularity has recently grown.
Health Care Counsel Gayland Hethcoat will share insights into the potential future of private equity (PE) in health care in a HealthExecStore webinar on April 16, 2025.
President Trump’s Executive Order (EO) 14187, “Protecting Children from Chemical and Surgical Mutilation,” represents a significant shift in federal policy regarding gender-affirming care (GAC) for minors.
Gayland Hethcoat was quoted on the potential for increased data privacy litigation targeting health plans, with the Blue Shield case possibly sparking a “broader wave” of lawsuits.
In a series of recent legal challenges initiated by the pharmaceutical industry against the US Department of Health and Human Services Office of the Inspector General (OIG), manufacturers have contested the OIG’s long-standing interpretation of the Anti-Kickback Statute (AKS).
On March 31, a judge in the Eastern District of Texas vacated the US Food and Drug Administration’s (FDA) rule that sought to regulate laboratory-developed tests (LDTs) as medical devices under the Federal Food, Drug, and Cosmetic Act (FDCA).
Partner David Greenberg was quoted on a series of patient lawsuits challenging the alleged use of artificial intelligence (AI) and algorithms by health insurers, commenting on the potential hazards of insurers using the technology.
Health Care Partner Debra Albin-Riley will participate in a session titled “Emerging Medical Staff Trends” at the California Society for Healthcare Attorneys’ (CSHA) 2025 Annual Meeting & Spring Seminar on April 6, 2025.
Health Care Partner Hillary Stemple was recently quoted on how physicians and other providers can navigate visits from drug and device manufacturer representatives, highlighting the legal and ethical complexities involved.